http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FI-854329-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
filingDate 1985-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e50d089bd7d9d32e849fe6005e430878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8328432714f5e559c04f649e1053f99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c9b3e2ba21b6bde6044625a1ed638b
publicationDate 1985-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FI-854329-A
titleOfInvention FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA BICYKLISKA BENSOFUSIONERADE FOERENINGAR.
abstract The invention relates to a method for production of new therapeutically useful bicyclic benzofused compounds with formula I, in which formula R2 and R3 each are hydrogen atoms or methyl groups, R1 is hydrogen or CH3CO-, Z is -O- CH(CH3)CH2CH2CH2- or -C(CH3)2(CH2)6-, and W is hydrogen or phenyl. The compounds with formula (I) are produced by reducing a compound with formula (IX) or (X), in which Y1 is hydrogen, methyl, benzyl, benzoyl or acetyl and R7 is hydrogen, methyl or ethyl, in the presence of a reaction- inert solvent by means of a metal hydride, preferably lithium aluminium hydride, or by catalytic hydration with a noble metal catalyst at a temperature of 0-60 degree C. <IMAGE>
priorityDate 1982-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456671281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449445756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 22.